Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

36

Revenue 2017

Xtandi

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Xtandi was produced by Astellas.

Takeda drops prostate cancer drug in phase III

Takeda drops prostate cancer drug in phase III Zytiga (abiraterone acetate), which brought in revenues of $1.7bn last year, and Astellas/Medivation's fast-growing Xtandi (enzalutamide) which pulled in almost $400m last year.  . ... A recent report by Decision Resources suggested Zytiga and Xtandi

Japanese product news in brief

Japanese product news in brief Home launch for Astellas' Xtandi, GSK files COPD drug for approval and more. ... Japan's Astellas has launched its new drug for castration-resistant prostate cancer - Xtandi (enzalutamide) - in its home market.

NICE backtracks on prostate cancer drug enzalutamide

NICE backtracks on prostate cancer drug enzalutamide Says Astellas and Medivation's Xtandi can be used within the NHS in England and Wales. ... Xtandi was approved in Europe last year and is predicted to make sales of more than $500m this year, mainly on the back of strong growth in the US.

Xtandi on course for pre-chemo use in prostate cancer

Xtandi on course for pre-chemo use in prostate cancer Medivation is also trying to position Xtandi earlier in the course of prostate cancer, as well as in other indications such as breast cancer. ... Medivation also has two phase II trials comparing Xtandi with Casodex, the most widely-used anti-androgen.

NICE gives partial backing to Ferring's prostate cancer drug

NICE gives partial backing to Ferring's prostate cancer drug Prostate Cancer UK is in the midst of a battle with NICE to try to convince the agency to reverse its decision to impose tight restrictions on prescribing of Astellas' Xtandi

[ Previous 5 results ] 8 9 10 11 12 13 14 15 16 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics